Antibiotics for exacerbations of chronic obstructive pulmonary disease (Q24202248)

4

object named as

Judith Garcia-Aymerich

0 references

Milo A Puhan

5

object named as

Milo A Puhan

0 references

author name string

Daniela J Vollenweider

1

0 references

Harish Jarrett

2

0 references

Claudia A Steurer-Stey

Cochrane Database of Systematic Reviews

3

0 references

publication date

12 December 2012

0 references

published in

0 references

cites work

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Antibiotic regimens in severe and acute purulent exacerbations of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Clinical effectiveness and safety of gemifloxacin versus cefpodoxime in acute exacerbation of chronic bronchitis: A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Rifamycin antibiotics in chronic purulent bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Effect of antibiotics on purulent sputum in chronic bronchitis and bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Value of ampicillin in the hospital treatment of exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

[ANTEAB: a study of early antibiotic therapy in intensive care management of acute exacerbations of chronic obstructive lung disease].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

INFLUENCE OF DAILY PENICILLIN, TETRACYCLINE, ERYTHROMYCIN, AND SULPHAMETHOXYPYRIDAZINE ON EXACERBATIONS OF BRONCHITIS. A REPORT TO THE RESEARCH COMMITTEE OF THE BRITISH TUBERCULOSIS ASSOCIATION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Antimicrobials in acute exacerbations of chronic obstructive pulmonary disease - An analysis of the time to next exacerbation before and after the implementation of standing orders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Use of antibiotics in patients admitted to the hospital due to acute exacerbation of chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Bacampicillin in acute exacerbations of chronic bronchitis--a dose-range study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

A comparative study of ampicillin, tetracycline hydrochloride, and methacycline hydrochloride in acute exacerbations of chronic bronchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Equal Effectiveness of Older Traditional Antibiotics and Newer Broad-Spectrum Antibiotics in Treating Patients with Acute Exacerbations of Chronic Bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

A comparison of erythromycin, novobiocin, tetracycline and a novobiocin—tetracycline combination in purulent exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: a randomised, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Multicentre audit of inpatient management of acute exacerbations of chronic obstructive pulmonary disease: comparison with clinical guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Exacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Toward a consensus definition for COPD exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Procalcitonin to initiate or withhold antibiotics in acute respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Antibiotics for exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Antibiotic regimens in moderately ill patients with purulent exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

A comparison of trimethoprim/sulphamethoxazole compound and tetracycline in exacerbations of chronic bronchitis: A double-blind multi-centre trial on in-patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

A winter-long trial of ampicillin in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

A comparison of pivampicillin and ampicillin in exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Antibiotic regimes in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

A comparison between ampicillin and tetracycline in purulent chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Exacerbations of chronic bronchitis treatment with oxytetracycline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Antibiotics for exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Trimethoprim-sulfamethoxazole in the treatment and prevention of purulent exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Treatment of acute exacerbations of chronic bronchitis with cefotaxime: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

A controlled study of the effect of treatment on chronic bronchitis. An evaluation using pulmonary function tests

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Chemotherapy in chronic bronchitis. Influence of daily penicillin and tetracycline on exacerbations and their cost

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

A Trial of Phenethicillin in Chronic Bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

A Comparison of Pivampicillin and Tetracycline in Exacerbations of Chronic Bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Efficacy of Antibiotic Therapy for Acute Exacerbations of Mild to Moderate Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Erythromycin and common cold in COPD

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

[Treatment effects of co-amoxiclav (Amoxiclav 2x) in acute exacerbation of severe chronic obstructive pulmonary disease: clinical evaluation]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Amoxicillin in treatment of acute uncomplicated exacerbations of chronic bronchitis. A double-blind, placebo-controlled multicentre study in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021

Antibiotic therapy of acute exacerbations of chronic bronchitis. A controlled study using tetracycline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010257

7 January 2021